Roivant Sciences (ROIV) Debt to Equity: 2021-2024
Historic Debt to Equity for Roivant Sciences (ROIV) over the last 3 years, with Jun 2024 value amounting to $0.03.
- Roivant Sciences' Debt to Equity fell 77.74% to $0.03 in Q2 2024 from the same period last year, while for Jun 2024 it was $0.03, marking a year-over-year decrease of 77.74%. This contributed to the annual value of $0.03 for FY2024, which is 75.07% down from last year.
- According to the latest figures from Q2 2024, Roivant Sciences' Debt to Equity is $0.03, which was up 10.91% from $0.03 recorded in Q1 2024.
- Over the past 5 years, Roivant Sciences' Debt to Equity peaked at $0.16 during Q3 2023, and registered a low of $0.02 during Q1 2022.
- Over the past 3 years, Roivant Sciences' median Debt to Equity value was $0.08 (recorded in 2024), while the average stood at $0.08.
- As far as peak fluctuations go, Roivant Sciences' Debt to Equity slumped by 80.84% in 2022, and later skyrocketed by 717.36% in 2023.
- Quarterly analysis of 4 years shows Roivant Sciences' Debt to Equity stood at $0.09 in 2021, then skyrocketed by 50.56% to $0.14 in 2022, then slumped by 75.81% to $0.03 in 2023, then tumbled by 77.74% to $0.03 in 2024.
- Its last three reported values are $0.03 in Q2 2024, $0.03 for Q1 2024, and $0.03 during Q4 2023.